Study after study show AI outperforming MDs in all areas. How should all-too-human physicians — who have trained for years to be good at what they do — feel about this? Medscape Medical News
Category: News
Both Parotid and Labial Gland Biopsies Can Diagnose SjS
Although largely similar, some important histopathologic differences were seen in the biopsies of the labial and parotid salivary glands in individuals with suspected SjS. Medscape Medical News
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release first…
iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging
NEW YORK–(BUSINESS WIRE)– #AI–iPredictTM glaucoma detection model provides a fully automated detection report for glaucoma which can be implemented in the primary care settings for screening and detection of early-stage glaucoma. The full US patent …
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $AMLX–Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the Company will host a virtual webcast with management and Fumihiko Urano, MD, PhD, Principal Investigator of the HELI…
拨康视云（Cloudbreak Pharma） 最新调查结果凸显眼疾负担，彰顯非手术治疗选项对于被低估和未充分治疗的翼状胬肉眼疾的重要性
加州尔湾–(BUSINESS WIRE)–(美国商业资讯)– 拨康视云是一家临床阶段的生物技术公司，致力于开发治疗常见但治療方案甚少的眼科疾病的药物。該公司在波士顿举行的年度ASCRS会议上分享了一项由公司支持的调查数据，该调查彰顯了翼状胬肉的患者负担。翼状胬肉是一种眼部疾病，通常被称为“冲浪者眼”，可能是暴露于高水平紫外线辐射環境而引起的。1 这项横断面调查显示，50％的受访者报告称翼状胬肉对他们的生活产生了相当大的影响，經常干扰他们进行日常活动的能力。2超过一半的受访患者还表示环境因素，如…
New Survey Results from Cloudbreak Pharma Highlight Disease Burden, Need for Non-surgical Treatment Options for Underdiagnosed and Undertreated Ocular Disease
IRVINE, Calif.–(BUSINESS WIRE)–Cloudbreak Pharma, a clinical stage biotechnology company developing ophthalmic drugs for common eye diseases with few treatment options, shared new data from a company-supported survey highlighting the patient burden o…
Dry Eye Syndrome Market Set for Rapid Growth as Aging Population Demand Soars – Global Long-term Forecast to 2028 and 2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Syndrome Global Market Report 2024” report has been added to ResearchAndMarkets.com’s offering. This research publication sheds light on the robust growth and pivotal trends propelling the sector forward, ensuring …
Global Allergy Conjunctivitis Market Projected to Reach $3.2 Billion by 2028, Driven by Increasing Allergies and Technological Innovations – Long-term Forecast to 2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergy Conjunctivitis Global Market Report 2024” report has been added to ResearchAndMarkets.com’s offering. Market Expansion Driven by Increasing Allergies and Technological Innovations in Treatment The global allergy co…
CGM Associated With Lower Retinopathy Risk in T1D
The use of continuous glucose monitoring (CGM) was linked to a reduced risk for diabetic retinopathy, a debilitating complication in adults with type 1 diabetes. Medscape Medical News
EyeCare Partners Announces New Refractive Cataract Anterior Segment Fellowship and Launch of ECP Foundation
ST. LOUIS–(BUSINESS WIRE)– #ASCRS–EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, continues to advance leadership and research at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting…
Wearing Glasses Boosts Income by a Third in Low-Income Communities, Finds Landmark New Study
NEW YORK–(BUSINESS WIRE)–A pair of reading glasses increases the earnings of people in low- income communities by 33% according to new research. A new randomised controlled trial, published today, finds that the provision of reading glasses improves …
Southern California College of Optometry Celebrates 120 Years of Educational and Clinical Excellence
FULLERTON, Calif.–(BUSINESS WIRE)–Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution headquartered in Fullerton, Calif. proudly celebrates the 120th anniversary of its Southern California Co…
Lenz Therapeutics’ Eye Disease Drugs Meet Main Goal Of Late-stage Study
Lenz Therapeutics said on Wednesday its experimental drugs to treat loss of near vision met the main goal of a late-stage study, sending its shares up nearly 23% before the… Reuters Health Information
Lenz Therapeutics’ Eye Drop Helps Improve Vision in Late-stage Study
Lenz Therapeutics said on Wednesday its lead experimental drug being tested in patients with a common age-related eye disorder showed improvement in nearsightedness in a… Reuters Health Information
LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials
SAN DIEGO–(BUSINESS WIRE)–LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop to improve near vision in people with presbyopia, t…
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced the U….
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc. will be presenting data on LACRIFILL® Canalicular Gel during the ASCRS Annual Meeting in Boston, MA on April 5-8, 2024.
Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
SEATTLE, CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced several presentations during the 2024 American Society of Cataract…
Roivant’s Anti-inflammatory Drug Succeeds in Mid-stage Study
Roivant Sciences said on Tuesday its experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending… Reuters Health Information